2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawley, JN; Paul, SM; Skolnick, P | 1 |
| File, SE; Lister, RG | 1 |
| Basile, AS; Fromm, C; Gu, ZQ; Holt, AG; Nowak, G; Yurdaydin, C | 1 |
3 other study(ies) available for 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one and Disease Models, Animal
| Article | Year |
|---|---|
Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Carbolines; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Flumazenil; Humans; Male; Mice; Pyrazoles | 1984 |
Interactions of ethyl-beta-carboline-3-carboxylate and Ro 15-1788 with CGS 8216 in an animal model of anxiety.
Topics: Animals; Anxiety; Benzodiazepinones; Carbolines; Disease Models, Animal; Drug Interactions; Flumazenil; Humans; Indoles; Male; Pyrazoles; Rats; Receptors, Cell Surface; Receptors, GABA-A; Social Behavior | 1983 |
Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.
Topics: Animals; Azides; Benzodiazepines; Benzodiazepinones; Brain; Disease Models, Animal; GABA-A Receptor Antagonists; Hepatic Encephalopathy; Ligands; Male; Motor Activity; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 1993 |